PeptideSearch

Sermorelin

Approved, discontinued

Get notified when the evidence changes.

The FDA approved a version of this in the past, but that product is no longer sold. It went through large studies in people.

Compiled and reviewed by the PeptideSearch Editorial Team · Status checked 2024-09-27

Also called GRF 1-29 / Geref / Sermorelin acetate

A shortened copy of a natural hormone that tells the body to make growth hormone. Doctors can prescribe it.

Official status: Pharmacies may compound it · Checked 2024-09-27

Can a doctor prescribe this?

Small pharmacy (503A)
Never put forward to FDA
Large outsourcing facility (503B)
Category 1 — under review, allowed for now

Was FDA-approved as Geref; the brand was discontinued. Pharmacies can still compound it with a prescription.

503A is a pharmacy making a single prescription for one patient. 503B is a facility making batches. They are governed by separate lists. Where a category is shown, it is a position on the FDA's list of substances that have been put forward and are still being worked through — not the final list, which is set by rulemaking. Category 1 means the FDA does not plan to act against a pharmacy that makes it while the review runs.

Lab suppliers we list: 13

Doses used in research

Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.

No dosing information has been published in the research indexed here.

Spot an error? corrections@peptidesearch.org

What has happened so far

  1. 21 March 2025503B

    FDA lists "Sermorelin Acetate" — the acetate salt, the form pharmacies handle — under 503B Category 1: Bulk Drug Substances Under Evaluation. Category 1 means FDA does not intend to act against an outsourcing facility compounding it while the evaluation continues; it is not the final 503B Bulks List. Read from the FDA 503B category document dated March 21, 2025.

    FDA

We'll email you when a new study, trial or status change lands for Sermorelin. Unsubscribe in one click.